Video
Over a Dozen FDA Approvals in 2024 Changed the Lung Cancer Field
Delve Into Data With Amivantamab Plus Lazertinib in EGFR-Mutated NSCLC: With Chandler Park, MD; and Stephen Liu, MD
Hematologic Oncology Field Sees Almost 20 FDA Approvals in 2024
How to Apply Research Developments in ALK-Positive NSCLC: With Chandler Park, MD, and Tejas Patil, MD
Five Under 5: Top Oncology Videos for the Week of 2/2
FDA Grants Breakthrough Device Designation to Serial CTRS AI Model for NSCLC
Oncology Experts Preview Top Abstracts From 2025 ASCO GU
Dr Somaiah on Ongoing Research With Novel Agents in Sarcomas
Dr Hamid on the Potential for Cancer Vaccines in Melanoma
Dr Orloff on Treatment Strategies for Rapidly Progressing Uveal Melanoma